Immune mechanisms of acute respiratory distress syndrome
急性呼吸窘迫综合征的免疫机制
基本信息
- 批准号:10406858
- 负责人:
- 金额:$ 4.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcidosisAcute Lung InjuryAdult Respiratory Distress SyndromeAlveolarAlveolar MacrophagesApplications GrantsBiological MarkersCD14 geneCellsCellular Indexing of Transcriptomes and Epitopes by SequencingClinicalClinical TrialsCritical CareDataDevelopmentDiseaseEdemaEndotheliumEnvironmentEpithelialEpitopesExposure toFCGR3B geneFeedbackFellowshipFlow CytometryFrequenciesFutureGenesGoalsGrantHumanHypersensitivityHypoxemiaImmuneImmunologyInflammationInflammatoryInflammatory ResponseInjuryIntensive Care UnitsInterferon Type IIKidney FailureLeadershipLungMaintenanceMedicineMentorsMessenger RNAMicroarray AnalysisMolecularMorbidity - disease rateNK Cell ActivationNatural Killer CellsPathogenesisPathogenicityPathway interactionsPatient-Focused OutcomesPatientsPeripheral Blood Mononuclear CellPhenotypePhysiciansPneumoniaPositioning AttributeProductionPublicationsRefractoryRegulationResearchResistanceRespiratory FailureRisk FactorsRoleSamplingScientistSepsisSerumShockSignal PathwaySurfaceSurvivorsSyndromeSystemTIS11 proteinTechniquesTechnologyTestingTrainingTraumaUniversitiesWritingbasecareercareer developmentchemokineclinical heterogeneitycognitive disabilitycytokineexperimental studyindexingmonocytemortalitymultidisciplinaryneutrophilnew therapeutic targetnon cardiogenic pulmonary edemanovelpotential biomarkerprotein expressionpsychiatric disabilityrecruitresponsible research conductsingle-cell RNA sequencingskillssurfactanttargeted biomarkertherapeutic targettranscriptometranscriptome sequencingtranscriptomicstranslational study
项目摘要
PROJECT SUMMARY/ABSTRACT
The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in the intensive care
unit due to overwhelming inflammation in the lung without effective disease modifying treatments. Two sub-
phenotypes of ARDS have been identified based on clinical parameters and biomarkers. Compared to hypo-
inflammatory ARDS, hyper-inflammatory ARDS is characterized by shock, acidosis, and elevated inflammatory
biomarkers. Patients with hyper-inflammatory ARDS have a higher mortality and may respond differentially to
treatment. The overarching goal of this training grant proposal is to utilize cutting edge immunology techniques
to dissect the immune mechanisms underlying ARDS development and the differentiation between the two
sub-phenotypes. In our preliminary data, we identified reduced expression of tristetraprolin (TTP), a negative
regulator of cytokine production, in natural killer (NK) cells of patients with ARDS. In Aim 1, we will investigate
the mechanisms by which TTP regulates NK cell activation. Additionally, we will use PrimeFlow, a novel flow
cytometry-based mRNA quantification technique, to determine if NK cells from patients with ARDS are
refractory to negative feedback by inflammatory cytokines due to reduced TTP expression. In Aim 2, we will
focus on discovery of immune mechanisms that differentiate hyper- and hypo-inflammatory ARDS. We have
found increased frequency of circulating inflammatory non-classical CD14-CD16+ monocytes in hyper-
inflammatory ARDS when compared to hypo-inflammatory ARDS patients. We propose using cellular indexing
of transcriptomes and epitopes with sequencing (CITE-seq) to investigate signaling pathways at the single cell
level in monocytes that differentiate hyper- and hypo-inflammatory ARDS. CITE-seq references single cell
RNA sequencing transcriptomic data to surface expression of proteins thereby correlating the transcriptome
with flow cytometric surface phenotypes. Together, aims 1 and 2 will test our overall hypotheses that NK
cells in ARDS patients are resistant to negative feedback due to reduced TTP expression, and
persistent activation of CD16+ non-classical monocytes determines the hyper-inflammatory phenotype
of ARDS. Further delineation of immune mechanisms in the development and maintenance of ARDS will
advance our understanding of its pathogenesis and identify potential therapeutic targets to modify the disease
course of ARDS. The research proposed within this training fellowship will be undertaken at the University of
Pittsburgh through a collaborative training environment between the Division of Pulmonary, Allergy and Critical
Care Medicine and Department of Immunology to develop research skills in translational human and
computational systems immunology. Formal training in the responsible conduct of research and scientific rigor
are included in this training proposal, and career development through presentation of research, publication
and a multi-disciplinary mentoring committee are aimed at continued progress towards developing an
independent physician-scientist career.
项目概要/摘要
急性呼吸窘迫综合征(ARDS)是重症监护室呼吸衰竭的常见原因
由于肺部严重炎症而没有有效的疾病缓解治疗。两个子
ARDS 的表型已根据临床参数和生物标志物进行了鉴定。与低
炎症性 ARDS、高炎症性 ARDS 的特点是休克、酸中毒和炎症升高
生物标志物。高炎症性 ARDS 患者的死亡率较高,并且对药物的反应可能存在差异
治疗。该培训拨款提案的总体目标是利用尖端的免疫学技术
剖析 ARDS 发展背后的免疫机制以及两者之间的区别
亚表型。在我们的初步数据中,我们发现三四脯氨酸 (TTP) 的表达减少,这是一种阴性
ARDS 患者自然杀伤 (NK) 细胞中细胞因子产生的调节因子。在目标 1 中,我们将调查
TTP 调节 NK 细胞激活的机制。此外,我们将使用 PrimeFlow,一种新颖的流程
基于细胞计数的 mRNA 定量技术,以确定来自 ARDS 患者的 NK 细胞是否
由于 TTP 表达减少,难以抵抗炎症细胞因子的负反馈。在目标 2 中,我们将
专注于发现区分高炎症和低炎症 ARDS 的免疫机制。我们有
发现循环炎症非经典 CD14-CD16+ 单核细胞的频率增加
与低炎症性ARDS患者相比,炎症性ARDS患者。我们建议使用细胞索引
通过测序 (CITE-seq) 分析转录组和表位,以研究单细胞的信号传导途径
单核细胞中区分高炎症和低炎症 ARDS 的水平。 CITE-seq 参考单细胞
RNA 测序转录组数据与蛋白质表面表达,从而将转录组关联起来
具有流式细胞表面表型。目标 1 和目标 2 将共同检验我们的总体假设:NK
由于 TTP 表达减少,ARDS 患者的细胞对负反馈具有抵抗力,并且
CD16+非经典单核细胞的持续激活决定了高炎症表型
急性呼吸窘迫综合征。进一步描述 ARDS 发生和维持的免疫机制将
增进我们对其发病机制的理解并确定潜在的治疗靶点来改变疾病
ARDS 的病程。本次培训奖学金中提议的研究将在英国大学进行
匹兹堡通过肺科、过敏科和危重症科之间的协作培训环境
护理医学和免疫学系开发转化人类和免疫学的研究技能
计算系统免疫学。负责任的研究行为和科学严谨性的正式培训
包含在本培训提案中,并通过研究报告、出版物的介绍和职业发展
和一个多学科指导委员会的目的是在发展
独立的医生科学家职业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian Robert Rosborough其他文献
Brian Robert Rosborough的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:














{{item.name}}会员




